PURADIGM® Announces Central Michigan University College of Medicine Test Results – Inactivation of BSL2 RNA Viruses
Study determines PURADIGM® ZONE Air and Surface Purification Technology Inactivates Dengue Virus Type 2 by 99% after a 24 hour time period
SAN DIEGO, CA / ACCESSWIRE / October 25, 2021 /PURADIGM®, a leading manufacturer of proactive air and surface purification technologies that have been proven to inactivate SARS-CoV-2, the virus responsible for COVID-19, and the Delta Variant, announced today that a study by the Central Michigan University College of Medicine showed that PURADIGM® ZONE technology, which combines bipolar ionization inactivation in the presence of oxidizers, successfully neutralized the Dengue Virus Type 2 (DENV2).
After 24 hours, the PURADIGM® ZONE treated sample showed a 99% reduction in infectious DENV2. Moreover, the PURADIGM® ZONE unit inactivated 80% of the DENV2 virus within the first 4-6 hours.
View Full Report:
Jim Gabriel, CEO of PURADIGM® commented; “We are extremely proud of our product and these results show that this technology can make a difference in any environment. This technology can help reduce the spread of infectious viruses in our communities and in turn make our environments a safer place for all.”